Comparison Between Triphasic CT Abdomen and EUS-FNB in Characterization of Pancreatic Lesion

evaluate the relationship between triphasic CT and EUS findings and the characterization of pancreatic lesions.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

EUS Guided Biopsy CT Scan Pancreatic Lesions Located at the Body or the Tail

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Comparison Between Triphasic CT and EUS-FNB in characterization of Pancreatic Lesions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

*Adult patients (age>18 years) presenting with focal pancreatic lesions detected on initial imaging.

Patients referred for further evaluation by triphasic CT and/or EUS-guided biopsy.
Patients able to provide informed consent

Exclusion criteria

Previous pancreatic surgery.

Known metastatic disease at presentation.
Contraindications to contrast-enhanced CT (e.g. severe renal impairment, contrast allergy)
Contraindications to EUS or biopsy (e.g., coagulopathy uncorrected, severe cardiopulmonary instability).
Pregnancy.

Treatment and study plan

Full clinical history (pain, jaundice, weight loss, pancreatitis history). Physical examination with focus on abdominal and systemic findings.

Diagnostic Test

Full clinical history (pain, jaundice, weight loss, pancreatitis history). Physical examination with focus on abdominal and systemic findings.

Primary outcomes

Diagnostic accuracy of triphasic CT compared to EUS-guided biopsy in differentiating benign from malignant pancreatic lesions.

Time frame: one year

the diagnostic accuracy of triphasic CT compared to EUS-guided biopsy in differentiating benign and malignant pancreatic lesions, calculated in terms of sensitivity, specificity, PPV, NPV, and overall accuracy, using final histopathological diagnosis as the reference standard.

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Abdullah Ashmawy, Prof. Dr

CONTACT

[email protected]

01005679880

Mohamed Mahdy, ProfDr

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2027
First posted: Feb 20, 2026
Registry last updated: Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting